Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Efficiency evaluation of dual-energy CT to predict the postoperative early recurrence of pancreatic ductal adenocarcinoma.

Autor: Yu SY; Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, No 300, Guangzhou Road, Nanjing, 210029, Jiangsu Province, China., Shu YP; Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, No 300, Guangzhou Road, Nanjing, 210029, Jiangsu Province, China., Bai XH; Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, No 300, Guangzhou Road, Nanjing, 210029, Jiangsu Province, China., Yu J; Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, No 300, Guangzhou Road, Nanjing, 210029, Jiangsu Province, China., Lu ZP; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, No 300, Guangzhou Road, Nanjing, 210029, Jiangsu Province, China., Jiang KR; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, No 300, Guangzhou Road, Nanjing, 210029, Jiangsu Province, China., Xu Q; Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, No 300, Guangzhou Road, Nanjing, 210029, Jiangsu Province, China. Electronic address: 13776683209@163.com.

Publikováno v: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] [Pancreatology] 2024 Nov; Vol. 24 (7), pp. 1123-1132. Date of Electronic Publication: 2024 Sep 14.

Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling.

Autor: Chen Q; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Jiang LY; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Cao C; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Liu FY; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Li DR; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Wu PF; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Jiang KR; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Publikováno v: Molecular carcinogenesis [Mol Carcinog] 2024 May; Vol. 63 (5), pp. 938-950. Date of Electronic Publication: 2024 Feb 14.

[Distal pancreatectomy with celiac axis resection for pancreatic body cancer: a single center review of 89 consecutive cases].

Autor: Huang XM; Pancreas Center,First Affiliated Hospital of Nanjing Medical University,Pancreas Institute,Nanjing Medical University,Nanjing 210029,China., Zhang K; Pancreas Center,First Affiliated Hospital of Nanjing Medical University,Pancreas Institute,Nanjing Medical University,Nanjing 210029,China., Yin J; Pancreas Center,First Affiliated Hospital of Nanjing Medical University,Pancreas Institute,Nanjing Medical University,Nanjing 210029,China., Wu PF; Pancreas Center,First Affiliated Hospital of Nanjing Medical University,Pancreas Institute,Nanjing Medical University,Nanjing 210029,China., Cai BB; Pancreas Center,First Affiliated Hospital of Nanjing Medical University,Pancreas Institute,Nanjing Medical University,Nanjing 210029,China., Lu ZP; Pancreas Center,First Affiliated Hospital of Nanjing Medical University,Pancreas Institute,Nanjing Medical University,Nanjing 210029,China., Tu M; Pancreas Center,First Affiliated Hospital of Nanjing Medical University,Pancreas Institute,Nanjing Medical University,Nanjing 210029,China., Chen JM; Pancreas Center,First Affiliated Hospital of Nanjing Medical University,Pancreas Institute,Nanjing Medical University,Nanjing 210029,China., Guo F; Pancreas Center,First Affiliated Hospital of Nanjing Medical University,Pancreas Institute,Nanjing Medical University,Nanjing 210029,China., Xi CH; Pancreas Center,First Affiliated Hospital of Nanjing Medical University,Pancreas Institute,Nanjing Medical University,Nanjing 210029,China., Wei JS; Pancreas Center,First Affiliated Hospital of Nanjing Medical University,Pancreas Institute,Nanjing Medical University,Nanjing 210029,China., Wu JL; Pancreas Center,First Affiliated Hospital of Nanjing Medical University,Pancreas Institute,Nanjing Medical University,Nanjing 210029,China., Gao WT; Pancreas Center,First Affiliated Hospital of Nanjing Medical University,Pancreas Institute,Nanjing Medical University,Nanjing 210029,China., Dai CC; Pancreas Center,First Affiliated Hospital of Nanjing Medical University,Pancreas Institute,Nanjing Medical University,Nanjing 210029,China., Miao Y; Pancreas Center,First Affiliated Hospital of Nanjing Medical University,Pancreas Institute,Nanjing Medical University,Nanjing 210029,China., Jiang KR; Pancreas Center,First Affiliated Hospital of Nanjing Medical University,Pancreas Institute,Nanjing Medical University,Nanjing 210029,China.

Publikováno v: Zhonghua wai ke za zhi [Chinese journal of surgery] [Zhonghua Wai Ke Za Zhi] 2023 Oct 01; Vol. 61 (10), pp. 894-900.

Suppressive effect of YY1-mediated RGS22 regulation on the proliferation, migration and invasion of pancreatic ductal adenocarcinoma.

Autor: Cao SJ; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.; Department of Thyroid Surgery, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu 222002, P.R. China., Ge WL; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.; Pancreas Institute, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China., Meng LD; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.; Pancreas Institute, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China., Chen Q; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.; Pancreas Institute, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China., Miao Y; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.; Pancreas Institute, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China., Jiang KR; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.; Pancreas Institute, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China., Zhang JJ; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.; Pancreas Institute, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.

Publikováno v: Oncology letters [Oncol Lett] 2022 Nov 02; Vol. 24 (6), pp. 457. Date of Electronic Publication: 2022 Nov 02 (Print Publication: 2022).